189 related articles for article (PubMed ID: 22836862)
21. EUS and survival in patients with pancreatic cancer: a population-based study.
Ngamruengphong S; Li F; Zhou Y; Chak A; Cooper GS; Das A
Gastrointest Endosc; 2010 Jul; 72(1):78-83, 83.e1-2. PubMed ID: 20620274
[TBL] [Abstract][Full Text] [Related]
22. A national propensity-adjusted analysis of adjuvant radiotherapy in the treatment of resected pancreatic adenocarcinoma.
McDade TP; Hill JS; Simons JP; Piperdi B; Ng SC; Zhou Z; Kadish SP; Fitzgerald TJ; Tseng JF
Cancer; 2010 Jul; 116(13):3257-66. PubMed ID: 20564625
[TBL] [Abstract][Full Text] [Related]
23. A comparative analysis of survival outcomes between pancreatectomy and chemotherapy for elderly patients with adenocarcinoma of the pancreas.
Marmor S; Burke EE; Virnig BA; Jensen EH; Tuttle TM
Cancer; 2016 Nov; 122(21):3378-3385. PubMed ID: 27419382
[TBL] [Abstract][Full Text] [Related]
24. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
[TBL] [Abstract][Full Text] [Related]
25. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
[TBL] [Abstract][Full Text] [Related]
26. The role of radiotherapy in patients with resected ampullary carcinoma: findings based on the SEER database.
Zhao W; Wang B; Zhao A; Tian Q; Zhang L; Wang L; Zhao X; Yang J; Dong D
HPB (Oxford); 2019 Nov; 21(11):1535-1540. PubMed ID: 31056288
[TBL] [Abstract][Full Text] [Related]
27. Treatment of locally advanced pancreatic cancer in the real world: population-based practices and effectiveness.
Krzyzanowska MK; Weeks JC; Earle CC
J Clin Oncol; 2003 Sep; 21(18):3409-14. PubMed ID: 12972517
[TBL] [Abstract][Full Text] [Related]
28. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
[TBL] [Abstract][Full Text] [Related]
29. Correlates of Refusal of Surgery in the Treatment of Non-metastatic Pancreatic Adenocarcinoma.
Coffman A; Torgeson A; Lloyd S
Ann Surg Oncol; 2019 Jan; 26(1):98-108. PubMed ID: 30145650
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic adenocarcinoma: effects of neoadjuvant therapy on post-pancreatectomy outcomes - an American College of Surgeons National Surgical Quality Improvement Program targeted variable review.
Czosnyka NM; Borgert AJ; Smith TJ
HPB (Oxford); 2017 Oct; 19(10):927-932. PubMed ID: 28747265
[TBL] [Abstract][Full Text] [Related]
31. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database.
Luo Y
Clin Transl Oncol; 2022 Jan; 24(1):76-83. PubMed ID: 34219204
[TBL] [Abstract][Full Text] [Related]
32. From street address to survival: Neighborhood socioeconomic status and pancreatic cancer outcomes.
Eskander MF; Hamad A; Li Y; Fisher JL; Oppong B; Obeng-Gyasi S; Tsung A
Surgery; 2022 Mar; 171(3):770-776. PubMed ID: 34876291
[TBL] [Abstract][Full Text] [Related]
33. Pancreatic cancer in the USA: persistence of undertreatment and poor outcome.
Enewold L; Harlan LC; Tucker T; McKenzie S
J Gastrointest Cancer; 2015 Mar; 46(1):9-20. PubMed ID: 25403828
[TBL] [Abstract][Full Text] [Related]
34. Surgery for Localized Pancreatic Cancer: The Trend Is Not Improving.
Strohl MP; Raigani S; Ammori JB; Hardacre JM; Kim JA
Pancreas; 2016; 45(5):687-93. PubMed ID: 26491905
[TBL] [Abstract][Full Text] [Related]
35. Management for Elderly Women With Advanced-Stage, High-Grade Endometrial Cancer.
Rauh-Hain JA; Pepin KJ; Meyer LA; Clemmer JT; Lu KH; Rice LW; Uppal S; Schorge JO; Del Carmen MG
Obstet Gynecol; 2015 Dec; 126(6):1198-1206. PubMed ID: 26551187
[TBL] [Abstract][Full Text] [Related]
36. Modest improvement in overall survival for patients with metastatic pancreatic cancer: a trend analysis using the surveillance, epidemiology, and end results registry from 1988 to 2008.
Worni M; Guller U; White RR; Castleberry AW; Pietrobon R; Cerny T; Gloor B; Koeberle D
Pancreas; 2013 Oct; 42(7):1157-63. PubMed ID: 23867367
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
Chen X; Liu G; Wang K; Chen G; Sun J
Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
[TBL] [Abstract][Full Text] [Related]
38. Radiotherapy benefited the survival of patients with intestinal-type gastric adenocarcinoma: a SEER population-based study.
Chu Y; Xu B; Song Q; Hu Q
Clin Transl Oncol; 2021 Jan; 23(1):164-171. PubMed ID: 32488805
[TBL] [Abstract][Full Text] [Related]
39. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
Shaib Y; Davila J; Naumann C; El-Serag H
Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
[TBL] [Abstract][Full Text] [Related]
40. Role of Adjuvant Radiotherapy in Left-Sided Pancreatic Cancer-Population-Based Analysis with Propensity Score Matching.
Lim YJ; Kim K; Chie EK; Kim B; Ha SW
J Gastrointest Surg; 2015 Dec; 19(12):2183-91. PubMed ID: 26376994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]